These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9795769)

  • 41. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
    Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
    J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glutamic acid decarboxylase and other autoantigens in IDDM.
    Nepom GT
    Curr Opin Immunol; 1995 Dec; 7(6):825-30. PubMed ID: 8679127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes.
    Jun HS; Khil LY; Yoon JW
    Cell Mol Life Sci; 2002 Nov; 59(11):1892-901. PubMed ID: 12530520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
    Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
    Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes.
    Yoon JW; Jun HS
    Arch Pharm Res; 1999 Oct; 22(5):437-47. PubMed ID: 10549569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
    Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
    J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigen-based immunotherapy drives the precocious development of autoimmunity.
    Tian J; Olcott AP; Kaufman DL
    J Immunol; 2002 Dec; 169(11):6564-9. PubMed ID: 12444168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD mice.
    Wiest-Ladenburger U; Fortnagel A; Richter W; Reimann J; Boehm BO
    Horm Metab Res; 1998 Oct; 30(10):605-9. PubMed ID: 9851666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
    Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
    J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
    Blancou P; Mallone R; Martinuzzi E; Sévère S; Pogu S; Novelli G; Bruno G; Charbonnel B; Dolz M; Chaillous L; van Endert P; Bach JM
    J Immunol; 2007 Jun; 178(11):7458-66. PubMed ID: 17513797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
    You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
    J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.